Original Article
Ethical problems arising from the use of placebo in clinical trials with drugs for migraine. Their analysis by the moral deliberation method
Problemas éticos por el uso de placebo en los ensayos clínicos con fármacos para la migraña. Análisis mediante el método de deliberación moral
a Servicio de Farmacología Clínica, Hospital Universitario La Paz, Madrid, Spain
b Área de Gestión Clínica de Neurociencias, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
c GlaxoSmithKline S.A., Tres Cantos, Madrid, Spain
d Departamento de Medicina Preventiva, Salud Pública e Historia de la Ciencia, Facultad de Medicina, Universidad Complutense, Madrid, Spain
e Departamento de Medicina Preventiva, Salud Pública e Inmunología y Microbiología Médicas, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Madrid, Spain
f R. Dal-Ré was working at the Medical Department of GlaxoSmithKline S.A., Tres Cantos, Madrid, Spain, while this paper was being drafted
Read
1869
Timeswas read the article
963
Total PDF
906
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 18 | 2 | 20 |
| 2025 11 | 50 | 25 | 75 |
| 2025 10 | 21 | 22 | 43 |
| 2025 9 | 12 | 17 | 29 |
| 2025 8 | 10 | 13 | 23 |
| 2025 7 | 16 | 16 | 32 |
| 2025 6 | 18 | 4 | 22 |
| 2025 5 | 13 | 9 | 22 |
| 2025 4 | 18 | 4 | 22 |
| 2025 3 | 25 | 13 | 38 |
| 2025 2 | 15 | 4 | 19 |
| 2025 1 | 30 | 2 | 32 |
| 2024 12 | 12 | 6 | 18 |
| 2024 11 | 21 | 5 | 26 |
| 2024 10 | 8 | 5 | 13 |
| 2024 9 | 4 | 7 | 11 |
| 2024 8 | 9 | 6 | 15 |
| 2024 7 | 4 | 6 | 10 |
| 2024 6 | 11 | 8 | 19 |
| 2024 5 | 8 | 11 | 19 |
| 2024 4 | 12 | 11 | 23 |
| 2024 3 | 12 | 14 | 26 |
| 2024 2 | 10 | 10 | 20 |
| 2024 1 | 4 | 10 | 14 |
| 2023 12 | 10 | 17 | 27 |
| 2023 11 | 8 | 19 | 27 |
| 2023 10 | 9 | 14 | 23 |
| 2023 9 | 3 | 5 | 8 |
| 2023 8 | 7 | 13 | 20 |
| 2023 7 | 19 | 25 | 44 |
| 2023 6 | 9 | 19 | 28 |
| 2023 5 | 5 | 27 | 32 |
| 2023 4 | 5 | 11 | 16 |
| 2023 3 | 3 | 4 | 7 |
| 2023 2 | 1 | 6 | 7 |
| 2023 1 | 7 | 6 | 13 |
| 2022 12 | 6 | 20 | 26 |
| 2022 11 | 9 | 15 | 24 |
| 2022 10 | 7 | 13 | 20 |
| 2022 9 | 8 | 28 | 36 |
| 2022 8 | 9 | 15 | 24 |
| 2022 7 | 11 | 9 | 20 |
| 2022 6 | 9 | 5 | 14 |
| 2022 5 | 12 | 9 | 21 |
| 2022 4 | 12 | 9 | 21 |
| 2022 3 | 7 | 10 | 17 |
| 2022 2 | 5 | 3 | 8 |
| 2022 1 | 7 | 9 | 16 |
| 2021 12 | 12 | 19 | 31 |
| 2021 11 | 6 | 8 | 14 |
| 2021 10 | 11 | 14 | 25 |
| 2021 9 | 3 | 11 | 14 |
| 2021 8 | 8 | 8 | 16 |
| 2021 7 | 7 | 6 | 13 |
| 2021 6 | 9 | 8 | 17 |
| 2021 5 | 7 | 10 | 17 |
| 2021 4 | 17 | 17 | 34 |
| 2021 3 | 14 | 10 | 24 |
| 2021 2 | 8 | 7 | 15 |
| 2021 1 | 6 | 15 | 21 |
| 2020 12 | 14 | 5 | 19 |
| 2020 11 | 5 | 4 | 9 |
| 2020 10 | 7 | 6 | 13 |
| 2020 9 | 3 | 8 | 11 |
| 2020 8 | 9 | 8 | 17 |
| 2020 7 | 8 | 13 | 21 |
| 2020 6 | 4 | 5 | 9 |
| 2020 5 | 7 | 9 | 16 |
| 2020 4 | 1 | 10 | 11 |
| 2020 3 | 5 | 5 | 10 |
| 2020 2 | 9 | 7 | 16 |
| 2020 1 | 12 | 18 | 30 |
| 2019 12 | 9 | 12 | 21 |
| 2019 11 | 5 | 4 | 9 |
| 2019 10 | 2 | 2 | 4 |
| 2019 9 | 0 | 2 | 2 |
| 2019 8 | 0 | 4 | 4 |
| 2019 7 | 4 | 9 | 13 |
| 2019 6 | 3 | 16 | 19 |
| 2019 5 | 28 | 28 | 56 |
| 2019 4 | 6 | 7 | 13 |
| 2019 3 | 2 | 3 | 5 |
| 2019 2 | 2 | 9 | 11 |
| 2019 1 | 1 | 0 | 1 |
| 2018 12 | 0 | 3 | 3 |
| 2018 11 | 0 | 1 | 1 |
| 2018 10 | 1 | 11 | 12 |
| 2018 9 | 6 | 5 | 11 |
| 2018 8 | 1 | 4 | 5 |
| 2018 7 | 3 | 1 | 4 |
| 2018 6 | 0 | 4 | 4 |
| 2018 5 | 0 | 3 | 3 |
| 2018 4 | 0 | 3 | 3 |
| 2018 1 | 1 | 0 | 1 |
| 2017 12 | 0 | 1 | 1 |
| 2017 11 | 3 | 3 | 6 |
| 2017 10 | 1 | 6 | 7 |
| 2017 9 | 1 | 5 | 6 |
| 2017 8 | 2 | 4 | 6 |
| 2017 7 | 1 | 0 | 1 |
| 2017 6 | 4 | 11 | 15 |
| 2017 5 | 4 | 1 | 5 |
| 2017 4 | 7 | 5 | 12 |
| 2017 3 | 15 | 20 | 35 |
| 2017 2 | 5 | 1 | 6 |
| 2017 1 | 1 | 1 | 2 |
| 2016 12 | 7 | 0 | 7 |
| 2016 11 | 11 | 0 | 11 |
| 2016 10 | 9 | 1 | 10 |
| 2016 9 | 8 | 1 | 9 |
| 2016 8 | 7 | 0 | 7 |
| 2016 7 | 5 | 0 | 5 |
Show all
